233-OR: The Beta-Cell Specific Deletion of Complement 1q-Like-3 Secreted Protein Improves Beta-Cell Function and Glucose Homeostasis

Abstract

Using bioinformatics network analysis, we identified complement-1q like-3 (C1ql3) as a secreted protein that affects pancreatic islet function in obese mice. Previously, we showed that the recombinant C1ql3 protein inhibits insulin secretion stimulated by exendin-4 (an agonist for GLP-1 receptor) from human and mouse islets. Currently, we are elucidating the role of C1ql3 in pancreatic β-cell function by using mice with β-cell-specific deletion of the C1ql3 (βKO) gene on a standard chow diet. C1ql3βKO mice showed significantly improved glucose clearance after oral glucose challenge than the control mice, whereas no difference in insulin sensitivity was observed. Moreover, the plasma insulin levels were significantly increased at 15 min after the glucose challenge in the C1ql3 βKO vs. control mice. However, islets isolated from C1ql3βKO significantly increased insulin secretion stimulated by cAMP and Exendin-4 than control islets. These results suggest that the loss of C1ql3 in β-cells increases insulin secretion to improve glucose tolerance. Adenovirus-mediated overexpression of C1ql3 in islets showed increased ER stress and decreased expression of genes involving β-cell function and maintenance. In pathophysiological conditions, increased C1ql3 expression coupled to secretion was observed from both T2D donor islets and obese mouse islets. Interestingly, reduction in C1ql3 secretion is inversely correlated with increased glucose-stimulated insulin secretion from islets of C1ql3βKOLeptinob/ob compared to Leptinob/ob control mice. These findings suggest that the loss of β-cell C1ql3 maintains ER stress and increases insulin secretion to maintain glucose homeostasis. Our work shows that an autocrine regulation of the C1ql3-signaling pathway contributes to β-cell dysfunction in obesity and type 2 diabetes. Disclosure M.Rahman: None. H.Alsharif: None. A.Michl: None. S.Bhatnagar: None. Funding National Institute of Diabetes and Digestive and Kidney Diseases (1R01DK120684-01)